Our study reveals that OTULIN significantly mitigates neuropathic pain and neuroinflammation in trigeminal neuralgia by activating autophagy and inhibiting the NLR family pyrin domain containing 3 inflammasome, highlighting its potential as a therapeutic target. The gene discussed is NLRP3; the disease is trigeminal neuralgia.